The treatment of oncological diseases of any type is somehow connected with the need for radiotherapy or chemotherapy – however, soon everything can change thanks to the new research work of specialists from the Massachusetts Institute of Technology who managed to create something unusual. Namely, scientists have found a way to make cytokines – natural immune cells that previously showed a high potential in the fight against cancer cells – can be firmly fixed inside the molecules of anti-cancer drugs without leaks.
Because in the natural environment this happens just like this – cytokines inevitably leave the shell of such molecules, causing negative consequences for healthy body cells. In order to establish the most high-quality and convenient way to fix them inside anti-cancer molecules, scientists have found that proteins called lumican and collagen are suitable candidates for fixing, the latter is most often found in cancer-damaged cells.
Specialists have already done preliminary studies in experimental mice that have been shown to induce cancerous damage to cells and have found that these two proteins can actually hold cytokines within the molecular envelope of anticancer drugs, thus preventing them from leaking – and this, in turn, is really positive action on healthy cells and bypasses them. Thus, specialists were able to find a way to preserve cytokines within their molecular envelopes.
And this means that very soon the team of specialists will present the final version of such an anti-cancer molecular substance that will be aimed exclusively at cancer-affected cells and which will avoid healthy ones – which seems to be something really interesting and unusual even by the standards of modern oncology. It remains only to wait for the successful completion of the case and the first detailed results regarding the experiment.